Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
about
Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms
description
наукова стаття, опублікована в травні 2015
@uk
name
Ruxolitinib- but not fedratini ...... megaly/constitutional symptoms
@en
type
label
Ruxolitinib- but not fedratini ...... megaly/constitutional symptoms
@en
prefLabel
Ruxolitinib- but not fedratini ...... megaly/constitutional symptoms
@en
P2093
P2860
P1433
P1476
Ruxolitinib- but not fedratini ...... megaly/constitutional symptoms
@en
P2093
F. Palandri
M. Baccarani
N. Polverelli
N. Vianelli
P2860
P304
P356
10.1007/S00277-015-2397-9
P577
2015-05-16T00:00:00Z